|
|
|
|
|||||
|
|
|
Exponent, Inc. (NASDAQ:EXPO) is included among the 15 Overlooked Dividend Stocks to Buy Right Now.
On November 2, Truist lowered its price target for Exponent, Inc. (NASDAQ:EXPO) from $100 to $90 while maintaining a Buy rating, according to a report by The Fly. The analyst noted that artificial intelligence could create new opportunities for the company as clients seek its expertise in failure analysis. However, there is also a risk that increased efficiencies from automation could reduce billable hours, and the consulting sector may continue to face pressure from such technological changes.
In its third-quarter report, Exponent, Inc. (NASDAQ:EXPO) highlighted strong performance, with double-digit net revenue growth driven by the strength of its diversified portfolio. Growth was particularly strong in dispute-related work across the energy, transportation, life sciences, and construction sectors. As AI becomes more integrated into safety-critical systems, the company is supporting clients in managing risks and innovating responsibly.
For Q3 2025, total revenue rose 8% to $147.1 million, while revenue before reimbursements increased 10% to $137.1 million, up from $136.3 million and $125.1 million, respectively, in the same period last year.
Exponent, Inc. (NASDAQ:EXPO) is a global engineering and scientific consulting firm that delivers multidisciplinary solutions for complex technical and scientific problems.
While we acknowledge the potential of EXPO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Best Dividend Growth Stocks to Buy Now and 15 Best DRIP Stocks to Own Right Now.
Disclosure: None.
| Nov-11 | |
| Nov-06 | |
| Oct-31 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-28 | |
| Oct-23 | |
| Oct-09 | |
| Sep-29 | |
| Sep-23 | |
| Sep-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite